⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

Official Title: A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS

Study ID: NCT05538130

Study Description

Brief Summary: The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) administered as a single agent and in combination with other study medications in people with solid tumors. This study is seeking participants who have an advanced solid tumor for which the available treatments are no longer effective in controlling their cancer. All participants in this study will receive PF-07799544. PF-07799544 comes as a tablet to take by mouth daily (initially 2 times per day, but this could change to once daily or another frequency). Depending on the part of the study, participants may also receive another study medicine. * In the first part of the study, people with melanoma or other solid tumors may also receive encorafenib. Encorafenib comes as a capsule and is taken once per day. * In the second part of the study, people with melanoma or other cancers with abnormalities in a gene called "BRAF" will receive PF-07799544 with other study medicines (for example, PF-07799933). Participants may receive the study medicines for about 2 years. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.

Detailed Description:

Eligibility

Minimum Age: 16 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Highlands Oncology Group, PA, Fayetteville, Arkansas, United States

Highlands Oncology Group, Fayetteville, Arkansas, United States

Highlands Oncology Group, PA, Rogers, Arkansas, United States

Highlands Oncology Group, Rogers, Arkansas, United States

Highlands Oncology Group, PA, Springdale, Arkansas, United States

Highlands Oncology Group, Springdale, Arkansas, United States

Highlands Oncology, Springdale, Arkansas, United States

Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center, Tampa, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Moffitt McKinley Hospital, Tampa, Florida, United States

Florida Eye Center at Florida Medical Clinic, Tampa, Florida, United States

Brigitte Harris Cancer Pavilion, Detroit, Michigan, United States

Henry Ford Hospital, Detroit, Michigan, United States

Columbia University Irving Medical Center, New York, New York, United States

CUIMC Research Pharmacy, New York, New York, United States

Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

Providence Cancer Institute Franz Clinic, Portland, Oregon, United States

Providence Portland Medical Center, Portland, Oregon, United States

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Fred Hutchinson Cancer Center, Seattle, Washington, United States

University of Washington Medical Center, Seattle, Washington, United States

Cross Cancer Institute, Edmonton, Alberta, Canada

The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada

Sunnybrook Research Institute, Toronto, Ontario, Canada

Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Jewish General Hospital, Montreal, Quebec, Canada

McGill University Health Centre, Montréal, Quebec, Canada

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus, Quebec City, Quebec, Canada

Contact Details

Name: Pfizer CT.gov Call Center

Affiliation: Pfizer

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: